News
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the ...
The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
Scientists have created an artificial RNA system that can copy itself using simple building blocks and temperature changes.
Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...
The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results